Our current computational analysis examined the important natural TMPRSS2 variations and their interactions with the S glycoprotein and two potential serine protease inhibitors, which could be useful to develop high-affinity and personalized drugs for the treating of COVID-19 patients. Here, TMPRSS2 is linked to COVID-19.